Japan drugmakers feeling the heat from copycats
Many emerging nations fail to protect IP rights
Tokyo
JAPAN's pharmaceutical companies are struggling to do business in emerging nations due to the proliferation of copycat drugs, with a Chinese firm allegedly making a drug for Ebola that Fujifilm Holdings Corp says infringes on its intellectual property rights.
Fujifilm plans to file a lawsuit against Sihuan Pharmaceutical Holdings Group to suspend production of a copycat of Avigan, whose patent is held by Fujifilm. But some emerging nations are not making active efforts to protect intellectual property rights.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
‘Extreme’ climate blamed for world’s worst wine harvest in 62 years
Sheng Siong Q1 net profit up 9.3% on higher revenue
Nestle sales growth sputters on US slump, vitamin snags
Hermes Q1 sales jump 17% on strong China demand
Cordlife’s independent auditor to retire after issuing disclaimer of opinion on FY2023 financials
Cutting the cord?: Events leading up to Cordlife’s MOH suspension and arrests of its directors, ex-group CEO